X0206 3 2018-09-26 0 0001716621 Ra Medical Systems, Inc. RMED 0001746687 Irwin Dean C/O RA MEDICAL SYSTEMS, INC. 2070 LAS PALMAS DRIVE CARLSBAD CA 92011 1 1 1 0 See Remarks Common Stock 248100 D Common Stock 2803852 I See Footnote Common Stock 148860 I By Spouse Stock Option (Right to Buy) 28.94 2028-06-04 Common Stock 250000 D Stock Option (Right to Buy) 28.94 2028-06-04 Common Stock 150000 I By Spouse Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. 15% of the RSUs shall vest on the 10th day of the first month following the expiration of the Lock-Up Period (as defined in the award agreement) (the "LP"), 15% of the RSUs shall vest on the 10th day of the second month following the expiration of the LP, 15% of the RSUs shall vest on the 15th day of the fourth month following the expiration of the LP, 15% of the RSUs shall vest on the 15th day of the fifth month following the expiration of the LP, 15% of the RSUs shall vest on the 20th day of the seventh month following the expiration of the LP, 15% of the RSUs shall vest on the 20th day of the eighth month following the expiration of the LP, and 10% of the RSUs shall vest on the 25th day of the tenth month following the expiration of the LP, subject to the applicable holder's continued service. In the event of a Change in Control (as defined in the Issuer's 2018 Stock Compensation Plan), 100% of the RSUs shall immediately become fully vested, subject to the applicable holder's continued service. Shares held of record by Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017, of which the reporting person serves as co-trustee. One-third of the shares subject to the option shall vest on June 4, 2019, and one thirty-sixth of the shares subject to the option shall vest monthly thereafter, subject to the applicable holder's continued service. If the applicable holder's employment with the Company is terminated by the Company without cause, one-hundred percent (100%) of the shares subject to the option that have not vested shall immediately vest. CEO, Co-President, CTO, and Chairman of Board Exhibit 24 - Power of Attorney /s/ Andrew Jackson, as Attorney-in-Fact 2018-09-26